Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
life sciences
national blog main
3
×
san francisco blog main
boston blog main
boston top stories
clinical trials
eli lilly
alexion pharmaceuticals
alnylam pharmaceutials
arrowhead pharmaceuticals
black diamond therapeutics
bladder cancer
blueprint medicines
boehringer ingelheim
boston
california life sciences association (clsa)
cancer
cancer drugs
deals
deciphera pharmaceuticals
dicerna pharmaceuticals
endometral cancer
europe blog main
european society for medical oncology
fda
glioblastoma
hepatitis b
indiana blog main
indiana top stories
johnson & johnson
loxo oncology
mike guerra
mirati therapeutics
national top stories
neurodegenerative diseases
new enterprise associates
primary hyperoxaluria
rna interference
san diego
What
companies
3
×
medicines
3
×
new
abandoning
ago
baggage
better
biotech
black
california
cancer
clinic
clinicians
community
cuts
deal
development
devices
diagnostics
diamond
dicerna
disease
drug
education
eluded
established
fight
free
fueled
gets
giving
hopes
interference
ipo
lead
leading
life
lines
long
molecular
Language
unset
Current search:
medicines
×
biotech
×
" national blog main "
×
companies
×
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
California Life Sciences Fueled by Education, Established Companies
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
